Table: Kobayashi Pharmaceutical - 9-MTH group results

Kobayashi Pharmaceutical

07/11/2023 06:00

Nov 7 (Reuters)- 
             Kobayashi Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Sep 30, 2023        Sep 30, 2022     Dec 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            119.12              114.28           172.00    
                 (+4.2 pct)          (+6.1 pct)       (+3.5 pct)  
  Operating         19.39               18.75            25.50    
                 (+3.4 pct)          (-3.5 pct)       (-4.4 pct)  
  Recurring         20.84               20.43            26.50    
                 (+2.0 pct)          (-2.8 pct)       (-6.3 pct)  
  Net               15.50               14.50            20.20    
                 (+6.9 pct)          (-2.6 pct)       (+0.9 pct)  
  EPS            203.64 yen          187.52 yen       265.74 yen  
  Ann Div                             90.00 yen        96.00 yen  
  -Q2 div         43.00 yen           38.00 yen                   
  -Q4 div                             52.00 yen        53.00 yen  
  
  NOTE - Kobayashi Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T